David Nicholls

Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase

Elsa D. Garcin, A.S. Arvai, R.J. Rosenfeld et al. · Nature Chemical Biology · 2008 · 270 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

The induction and maintenance of flowering in <i>Impatiens</i>

Sylvie Pouteau, David Nicholls, Fiona Tooke et al. · Development · 1997 · 97 citations

Life Sciences, Botany, Plant Sciences +15

1,2-Dihydro-4-quinazolinamines:  Potent, Highly Selective Inhibitors of Inducible Nitric Oxide Synthase Which Show Antiinflammatory Activity in Vivo

Alan C. Tinker, Haydn G. Beaton, N. K. Boughton-Smith et al. · Journal of Medicinal Chemistry · 2003 · 96 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist

David Nicholls, Katherine Wiley, Ian Dainty et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 90 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2

David Nicholls, Nick P. Tomkinson, Katherine Wiley et al. · Molecular Pharmacology · 2008 · 85 citations

Medicine, Molecular Biology, Pharmacology +17